Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10)

References

• Siegel RL, Miller KD, Fuchs HE Cancer Statistics, 2021 . CA Cancer J Clin. 2020;711 ;359.
   Web of Science ®Google Scholar
• Peres LC, Cushing-Haugen KL, Martin K, et al. Invasive epithelial ovarian cancer survival by histotype and disease stage J Natl Cancer Inst . 2018;111(1): 60–68 .
   Google Scholar
• Parker F, Maurier F, Delumeau I, et al. A Ras-GTPase-activating protein SH3-domain-binding protein. Mol Cell Biol. 1996;16(6) ;2561–2569.
   PubMed Web of Science ®Google Scholar
• Ribbeck K, Lipowsky G, Kent HM, et al. NTF2 mediates nuclear import of Ran. The EMBO Journal. 1998;17(22):6587–6598.
   PubMed Web of Science ®Google Scholar
• Tsai WC, Gayatri S, Reineke LC, et al. Arginine Demethylation of G3BP1 promotes stress granule assembly. J Biol Chem . 2016;291(43) :22671–22685.
   PubMed Web of Science ®Google Scholar
• Yang P, Mathieu C, Kolaitis RM, et al. G3BP1 Is a tunable switch that triggers phase separation to assemble stress granules. Cell. 2020;181(2):325–345.e328.
   PubMed Web of Science ®Google Scholar
• Somasekharan SP, Zhang F, Saxena N, et al. G3BP1-linked mRNA partitioning supports selective protein synthesis in response to oxidative stress. Nucleic Acids Res. 2020;48(12):6855–6873.
   PubMed Web of Science ®Google Scholar
• Liu ZS, Cai H, Xue W, et al. G3BP1 promotes DNA binding and activation of cGAS. Nat Immunol . 2019;20(1):18–28 .
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang S, He H, et al. RasGAP-derived peptide 38GAP potentiates the cytotoxicity of cisplatin through inhibitions of Akt, ERK and NF-kappaB in colon carcinoma HCT116 cells. Cancer Lett. 2011;308(1):62–70.
   PubMed Web of Science ®Google Scholar
• Zhao J, Fu X, Chen H, et al. G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer. Br J Cancer . 2020;124(2) 425–436 .
   PubMed Web of Science ®Google Scholar
• Deng L, Meng T, Chen L, et al. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5(1):11.
   PubMed Web of Science ®Google Scholar
• Lim R, Sugino T, Nolte H, et al. Deubiquitinase USP10 regulates Notch signaling in the endothelium. Science. 2019;364(6436):188–193.
   PubMed Web of Science ®Google Scholar
• Luo P, Qin C, Zhu L, et al. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6. Hepatology. 2018;68(5):1786–1803.
   PubMed Web of Science ®Google Scholar
• Zhu H, Yan F, Yuan T, et al. USP10 promotes proliferation of hepatocellular carcinoma by deubiquitinating and stabilizing YAP/TAZ. Cancer Res. 2020;80(11):2204–2216.
   PubMed Web of Science ®Google Scholar
• Grunda JM, Nabors LB, Palmer CA, et al. Increased expression of Thymidylate Synthetase (TS), Ubiquitin Specific Protease 10 (USP10) and survivin is associated with poor survival in Glioblastoma Multiforme (GBM). J Neurooncol. 2006;80(3):261–274.
   PubMed Web of Science ®Google Scholar
• Li L, Luo Q, Xie Z, et al. Characterization of the expression of the RNA Binding Protein eIF4G1 and its clinicopathological correlation with serous ovarian cancer. PLoS One. 2016;11(9):e0163447.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang W, Huang S, et al. The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts. Genome Biol. 2018;19(1):35.
   PubMed Web of Science ®Google Scholar
• Liu J, Xie Y, Guo J, et al. Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nat Commun. 2021;12(1):1022.
   PubMed Web of Science ®Google Scholar
• Guillén-Boixet J, Kopach A, Holehouse AS, et al. RNA-Induced Conformational Switching and Clustering of G3BP drive stress granule assembly by condensation. Cell. 2020;181(2):346–361.e317.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang J, Shen X, et al. LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1. J Exp Clin Cancer Res. 2021;40(1):101.
   PubMed Web of Science ®Google Scholar
• Varjosalo M, Sacco R, Stukalov A, et al. Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. Nature Methods. 2013;10(4):307–314.
   PubMed Web of Science ®Google Scholar
• Bobby-Joe B, Chris S, Teresa R, et al. The BioGRID interaction database: 2008 update. Nucleic Acids Res . 2008;36(Database issue) ;D637–D640.
   PubMed Web of Science ®Google Scholar
• Bérdy J. Bioactive microbial metabolites - A personal view. J Antibiot (Tokyo) . 2005;58(1) :1–26.
   PubMed Web of Science ®Google Scholar
• Subramani R, Aalbersberg WJMR. Marine actinomycetes: an ongoing source of novel bioactive metabolites. Microbiol Res. 2012;167(10):571–580.
   PubMed Web of Science ®Google Scholar
• Abdelmohsen UR, Grkovic T, Balasubramanian S, et al. Elicitation of secondary metabolism in actinomycetes. Biotechnol Adv . 2015;33(6 Pt 1): 798–811 .
   PubMed Web of Science ®Google Scholar
• Fischer JW, Busa VF, Shao Y, et al. Structure-Mediated RNA Decay by UPF1 and G3BP1. Mol Cell . 2020;78(1): 70–84.e6 .
   PubMed Web of Science ®Google Scholar
• Meyer C, Garzia A, Morozov P, et al. The G3BP1-Family-USP10 deubiquitinase complex rescues ubiquitinated 40S subunits of ribosomes stalled in translation from lysosomal degradation. Mol Cell . 2020;77(6) 1193–1205.e5 .
   PubMed Web of Science ®Google Scholar
• Jung Y, Kim HD, Yang HW, et al. Modulating cellular balance of Rps3 mono-ubiquitination by both Hel2 E3 ligase and Ubp3 deubiquitinase regulates protein quality control. Exp Mol Med. 2017;49(11):e390–e390.
   PubMed Web of Science ®Google Scholar
• Kedersha N, Panas M, Achorn CA, et al. G3BP–Caprin1–USP10 complexes mediate stress granule condensation and associate with 40S subunits. J Cell Biol . 2016;212(7) :845–860.
   PubMed Web of Science ®Google Scholar
• Ko A, Han SY, Choi CH, et al. Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF. Cell Death Differ. 2018;25(6):1050–1062.
   PubMed Web of Science ®Google Scholar
• Lin Z, Yang H, Tan C, et al. USP10 Antagonizes c-Myc Transcriptional Activation through SIRT6 stabilization to suppress tumor formation. Cell Rep . 2013;5(6): 1639–1649 .
   PubMed Web of Science ®Google Scholar
• Zeng Z, Wu HX, Zhan N, et al. Prognostic significance of USP10 as a tumor-associated marker in gastric carcinoma. Tumour Biol. 2014;35(4):3845–3853.
   PubMedGoogle Scholar
• Hu C, Zhang M, Moses N, et al., Disease. The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53. Cell Death Dis . 2020;11(328): 5 .
   PubMed Web of Science ®Google Scholar
• Han GH, Chay DB, Yi JM, et al. Loss of both USP10 and p14ARF protein expression is an independent prognostic biomarker for poor prognosis in patients with epithelial ovarian cancer. Cancer Genomics Proteomics. 2019;16(6):553–562.
   PubMed Web of Science ®Google Scholar
• Anisimov S, Takahashi M, Kakihana T, et al. G3BP1 inhibits ubiquitinated protein aggregations induced by p62 and USP10. Sci Rep. 2019;9(1):12896 .
   PubMed Web of Science ®Google Scholar
• Jian Y, Luo K, Zhang L, et al. USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 2010;140(3):384–396.
   PubMed Web of Science ®Google Scholar
• Soncini C, Berdo I, Draetta G. Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease. Oncogene. 2001;20(29):3869–3879.
   PubMed Web of Science ®Google Scholar